RPG Life Sciences Limited (NSE:RPGLIFE)
India · Delayed Price · Currency is INR 2,630.00
+23.80 (0.91%)
Nov 12, 2026, 3:30 PM IST
RPG Life Sciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 7,643 | 7,076 | 6,534 | 5,821 | 5,128 | 4,402 |
Revenue Growth | 14.69% | 8.28% | 12.26% | 13.50% | 16.50% | 13.11% |
Gross Profit Gross Profit Growth | 4,930 | 4,500 | 4,342 | 3,928 | 3,370 | 2,932 |
Operating Income Operating Income Growth | 1,330 | 1,259 | 1,394 | 1,111 | 881 | 707.4 |
Net Income Net Income Growth | 1,092 | 1,152 | 1,832 | 876.6 | 676.4 | 514.8 |
Earnings Per Share EPS Growth | 66.95 | 69.64 | 110.79 | 53.00 | 40.90 | 31.13 |
EPS Growth | -48.60% | -37.15% | 109.03% | 29.60% | 31.39% | 28.70% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 4,834 | 4,224 | 3,873 | 3,419 | 3,046 |
Outside India Outside India Growth | 2,241 | 2,310 | 1,947 | 1,709 | 1,356 |
Total Total Growth | 7,075 | 6,534 | 5,821 | 5,128 | 4,402 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,922 | 2,744 | 2,646 | 1,259 | 1,148 | 698 |
Total Debt Total Debt Growth | 264.4 | 200 | - | - | 0.1 | 9.4 |
Net Cash (Debt) Net Cash Growth | 2,658 | 2,544 | 2,646 | 1,259 | 1,148 | 688.6 |
Net Cash Growth | 18.91% | -3.87% | 110.22% | 9.65% | 66.70% | 79.60% |
Net Cash Per Share Net Cash Per Share Growth | 162.95 | 153.80 | 159.99 | 76.10 | 69.41 | 41.63 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 557.2 | 565 | 778.6 | 943.6 | 908.2 | 647.5 |
Capital Expenditures CapEx Growth | -667.3 | -653.6 | -360.3 | -692.3 | -327.3 | -239.5 |
Free Cash Flow Free Cash Flow Growth | -110.1 | -88.6 | 418.3 | 251.3 | 580.9 | 408 |
Free Cash Flow Growth | - | - | 66.45% | -56.74% | 42.38% | -18.01% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 64.50% | 63.59% | 66.45% | 67.48% | 65.72% | 66.62% |
Operating Margin | 17.40% | 17.79% | 21.33% | 19.08% | 17.18% | 16.07% |
Pretax Margin | 19.31% | 21.79% | 35.64% | 20.25% | 17.88% | 16.62% |
Profit Margin | 14.29% | 16.28% | 28.04% | 15.06% | 13.19% | 11.70% |
FCF Margin | -1.44% | -1.25% | 6.40% | 4.32% | 11.33% | 9.27% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 24.000 | 24.000 | 20.000 | 16.000 | 12.000 | 9.600 |
Dividend Per Share Growth | 0% | 20.00% | 25.00% | 33.33% | 25.00% | 33.33% |
Dividend Yield | 0.91% | 1.29% | 0.88% | 1.05% | 1.71% | 1.71% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 39.28 | 26.68 | 20.59 | 28.84 | 17.13 | 18.01 |
P/FCF Ratio | - | - | 90.21 | 100.59 | 19.94 | 22.72 |
PS Ratio | 5.69 | 4.34 | 5.78 | 4.34 | 2.26 | 2.11 |